Abstract: Salmonellosis is a highly contagious, zoonotic disease affecting both animal and human health. Early characterization of emerging Salmonella serotypes and associated antimicrobial resistance patterns are essential for outbreak controls in animals and humans. Between 2018 and 2025, 245 Salmonella enterica subsp. enterica were isolated from both ante-mortem and post-mortem equine cases. The predominant Salmonella serotypes were Typhimurium (83), Newport (28), 1,4,[5],12:i:- (26), Saintpaul (25), Hartford (15), and Mbandaka (12). S. Saintpaul, previously rare in horses, was detected in 21 cases in 2025, all originating from Central Kentucky, and was associated with enterocolitis, bronchopneumonia, omphalitis, and septicemia, primarily in young foals. Sixteen S. Saintpaul isolates were subjected to whole genome sequencing and exhibited a White-Kauffmann-Le Minor scheme antigenic profile of 1,4,[5],12:e,h:1,2, consistent with previously reported S. Saintpaul strains. Multi-locus sequence typing assigned all isolates to sequence type ST50. Core genome MLST revealed low genetic diversity among the isolates, suggesting closely related strain cluster. Antimicrobial susceptibility testing revealed widespread multi-drug resistance, particularly to aminoglycosides, beta-lactams, tetracyclines and sulfonamides. Genotypic analysis confirmed the presence of antimicrobial resistance genes, including bla (not previously reported in Salmonella from horses), bla, sul1, dfrA34, and rmtE1, aligning with phenotypic findings. S. Saintpaul isolates harbored multiple plasmids, primarily of the IncI-gamma/K1 and, to a lesser extent, ColRNAI family. IncI-gamma/K1 plasmids were consistently associated with the MOB relaxase and MPF_I mating pair formation system. The emergence of multi-drug-resistant S. Saintpaul in horses underscores the importance of continued surveillance and antimicrobial resistance monitoring to mitigate animal and zoonotic risks.
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.
Overview
This research examines the emergence and genetic characteristics of Salmonella enterica serotype Saintpaul isolated from horses, highlighting its antimicrobial resistance and potential impact on animal and human health.
Background and Importance
Salmonellosis is a contagious zoonotic disease affecting both animals and humans, making early identification of Salmonella serotypes critical.
Understanding antimicrobial resistance patterns aids in controlling outbreaks in animals and reducing zoonotic transmission risks.
Salmonella enterica serotype Saintpaul was previously rare in horses but has recently been detected more frequently, indicating an emerging health concern.
Study Scope and Methods
Between 2018 and 2025, a total of 245 Salmonella enterica subsp. enterica isolates were collected from horses, from both ante-mortem (before death) and post-mortem (after death) cases.
The predominant serotypes identified were:
Typhimurium (83 isolates)
Newport (28 isolates)
1,4,[5],12:i:- (26 isolates)
Saintpaul (25 isolates)
Hartford (15 isolates)
Mbandaka (12 isolates)
S. Saintpaul cases mainly surfaced in 2025, with 21 isolates from Central Kentucky associated with diseases such as enterocolitis, bronchopneumonia, omphalitis (infection of the umbilical region), and septicemia, primarily affecting young foals.
Sixteen S. Saintpaul isolates underwent whole genome sequencing (WGS) to detail their genomic features.
Genomic Findings
Antigenic profile analysis using the White-Kauffmann-Le Minor scheme showed the isolates had the profile 1,4,[5],12:e,h:1,2, consistent with known S. Saintpaul strains.
All isolates were assigned the sequence type ST50 by multi-locus sequence typing (MLST), indicating a common lineage.
Core genome MLST (cgMLST) revealed low genetic diversity among the isolates, suggesting they form a closely related cluster or outbreak.
Antimicrobial Resistance Characteristics
Antimicrobial susceptibility testing demonstrated widespread multi-drug resistance (MDR), especially to:
Aminoglycosides
Beta-lactams
Tetracyclines
Sulfonamides
Genotypic analysis confirmed the presence of several antimicrobial resistance genes, such as:
bla genes (beta-lactam resistance genes, including types not previously reported in equine Salmonella)
sul1 (sulfonamide resistance)
dfrA34 (trimethoprim resistance)
rmtE1 (aminoglycoside resistance via methylation)
Plasmid Analysis
S. Saintpaul isolates contained multiple plasmids belonging mainly to:
IncI-gamma/K1 family plasmids
ColRNAI family plasmids, to a lesser extent
The IncI-gamma/K1 plasmids consistently carried:
MOB relaxase, an enzyme involved in plasmid mobilization
MPF_I mating pair formation system, which facilitates plasmid transfer between bacteria
These plasmids likely contribute to the spread of antimicrobial resistance within these bacterial populations.
Implications and Conclusions
The emergence of multi-drug resistant S. Saintpaul in horses signals a potential new threat to animal health, particularly in young foals in Central Kentucky.
Ongoing genomic surveillance and antimicrobial resistance monitoring are crucial to:
Detect and control outbreaks early
Limit the spread of resistant strains among animal populations
Reduce zoonotic risk to humans who come into contact with infected horses
This study underscores the necessity of integrating genomic tools in veterinary pathogen surveillance to better understand epidemiology and resistance mechanisms.
Cite This Article
APA
Uprety T, Shaffer CL, Loynachan A, Janes J, Cassone L, Kennedy L, Bryant U, Ruby R, Swan M, Sponseller BT, Adam E, Lubbers B, Erol E.
(2026).
Genomic characterization of Salmonella enterica serotype Saintpaul isolates from horses.
Vet Microbiol, 314, 110923.
https://doi.org/10.1016/j.vetmic.2026.110923
University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA. Electronic address: tirth.uprety@uky.edu.
Shaffer, Carrie L
University of Kentucky Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center, Lexington, KY, USA.
Loynachan, Alan
University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA.
Janes, Jennifer
University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA.
Cassone, Lynne
University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA.
Kennedy, Laura
University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA.
Bryant, Uneeda
University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA.
Ruby, Rebecca
University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA.
Swan, Melissa
University of Kentucky Veterinary Diagnostic Laboratory, Lexington, KY, USA.
Sponseller, Beatrice T
University of Kentucky Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center, Lexington, KY, USA.
Adam, Emma
University of Kentucky Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center, Lexington, KY, USA.
Lubbers, Brian
Kansas State University, College of Veterinary Medicine, Manhattan, KS, USA.
Erol, Erdal
University of Kentucky Department of Veterinary Science and the Maxwell H. Gluck Equine Research Center, Lexington, KY, USA. Electronic address: Erdal.erol@uky.edu.
MeSH Terms
Animals
Horses / microbiology
Salmonella Infections, Animal / microbiology
Salmonella Infections, Animal / epidemiology
Salmonella enterica / genetics
Salmonella enterica / drug effects
Salmonella enterica / isolation & purification
Salmonella enterica / classification
Horse Diseases / microbiology
Horse Diseases / epidemiology
Serogroup
Drug Resistance, Multiple, Bacterial / genetics
Multilocus Sequence Typing / veterinary
Anti-Bacterial Agents / pharmacology
Microbial Sensitivity Tests
Whole Genome Sequencing / veterinary
Genome, Bacterial
Genetic Variation
Conflict of Interest Statement
Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.